Mary Bird Perkins Cancer Center is launching a $10 million adaptive radiation therapy program that uses a technology designed in Sweden to enhance the precision of radiation doses, the organization ...

For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or ...

BOROUGH PARK — MAIMONIDES CANCER CENTER HAS LAUNCHED A POWERFUL new technology and approach to standard radiation oncology therapy with a state-of-the-art Adaptive Radiation Therapy (ART) system that ...

From Laura Bassi to Marie Curie, for centuries, women have been making important contributions to the world of physics. Now with ViewRay’s MRIdian system, women are leading the charge in bringing the ...

Mary Bird Perkins Cancer Center plans to invest $10 million for a new cancer treatment program at its Baton Rouge hospital that will allow oncologists to target tumors not typically treatable with ...

Simply put, a linear accelerator is the machine that is used to deliver radiation therapy to destroy a tumor. In standard radiation therapy, the medical team uses sophisticated imaging to pinpoint the ...

New Hyde Park, N.Y.-based Northwell Health’s Greenlawn and Lake Success radiation therapy centers are among the first in their area to offer adaptive radiation therapy. Varian Ethos radiation therapy ...

The fundamental tools of cancer treatment have largely been identified. Surgery, radiation, chemotherapy, and, most recently, immunotherapy form the key components of many treatment plans. So, when ...

ProtOnART builds upon the partners’ long-standing research efforts and shared ambition that an online adaptive workflow has the potential to significantly increase the quality of cancer treatments by ...

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic ...

Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers Symposium. This ...